Latest News

3Novices:Johnson & Johnson pays big for Swiss biotech firm Actelion

US healthcare giant Johnson & Johnson is to buy biotech company Actelion to access its highly profitable range of medicines for rare diseases.

http://ift.tt/2j8dcp7
3Novices Europe

No comments:

Post a Comment

Designed by 3Novices Copyright ©2011-2015

Theme images by Bim. Powered by Blogger.